These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Actions of the Clostridium botulinum binary toxin on the structure and function of Y-1 adrenal cells.
    Author: Zepeda H, Considine RV, Smith HL, Sherwin JR, Ohishi I, Simpson LL.
    Journal: J Pharmacol Exp Ther; 1988 Sep; 246(3):1183-9. PubMed ID: 2843629.
    Abstract:
    The binary toxin produced by Clostridium botulinum, also known as type C2 toxin, was examined for its ability to alter the structure and function of Y-1 cells, a murine adrenocortical tumor line. The toxin produced time- and concentration-dependent changes in morphology, characterized by retraction of cell extensions and by rounding of the cell body. These changes were not accompanied by increases or decreases in tissue levels of c-AMP or c-GMP, although there was an increase in the release of total steroids. When cells were exposed to toxin for 24 hr there was no evidence of cell death or lysis. Total nucleic acid content and the rate of incorporation of 14C-leucine into protein were comparable in control cells and intoxicated cells. The toxin has been shown to possess mono(ADP-ribosyl)ating activity, and actin is the presumed substrate. When Y-1 cells were ruptured and then exposed to the toxin in the presence of 32P-NAD, actin was ADP-ribosylated. When cells were exposed to the toxin before being ruptured, there was a subsequent loss in the amount of actin that was available for ADP-ribosylation (32P-NAD) in the broken cell assay. The data suggest that Y-1 cells can survive challenge with the botulinum binary toxin, and thus they are a suitable tissue in which to use the toxin as a pharmacological tool.
    [Abstract] [Full Text] [Related] [New Search]